Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS US) stock market data APIs
22.0817
0(0%)
as of June 11, 2025
Try our APIs with
free plan!
Invesco BulletShares 2028 High Yield Corporate Bond ETF Financial Data Overview
Prev. Close
22.0817
Open
22.0817
High
22.0629
Low
21.6452
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Invesco BulletShares 2028 High Yield Corporate Bond ETF data using free add-ons & libraries
End-of-day & Earnings data
Get Invesco BulletShares 2028 High Yield Corporate Bond ETF Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Invesco BulletShares 2028 High Yield Corporate Bond ETF End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Invesco BulletShares 2028 High Yield Corporate Bond ETF News
New
Banta Asset Management Lp Buys PowerShares QQQ Trust Ser 1, Invesco BulletShares 2027 High ...
Newport Beach, CA, based Investment company Banta Asset Management Lp (Current Portfolio) buys PowerShares QQQ Trust Ser 1, Invesco BulletShares 2027 High Yield Corporate Bon, The Home Depot Inc, Inve...
Invesco Provides Estimated Capital Gain Distribution Information for 2021
ATLANTA, Nov. 29, 2021 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ), a leading global provider of exchange-traded funds (ETFs), announced today that it expects to deliver capital gains distributions acros...
Is Weakness In Haemonetics Corporation (NYSE:HAE) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
It is hard to get excited after looking at Haemonetics' (NYSE:HAE) recent performance, when its stock has declined 45% over the past three months. However, stock prices are usually driven by a company...
Is Weakness In Haemonetics Corporation (NYSE:HAE) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
It is hard to get excited after looking at Haemonetics' (NYSE:HAE) recent performance, when its stock has declined 45% over the past three months. However, stock prices are usually driven by a company...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
